Great Science.
Greater Cause.
Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases.
Our Mission
Precigen’s mission is to discover, develop and commercialize next generation gene and cell therapies focused in immuno-oncology, autoimmune disorders, and infectious diseases.
Our Vision
Precigen’s vision is to develop life-saving and cost-conscious therapies utilizing our cutting-edge therapeutic and platform technologies for patients with unmet medical need.
Our Operating Principles
Responsible capital allocation to ensure runway for maximum value creation
Continuous evaluation of portfolio based on data to make rapid go/no go decisions
Focus on rapid execution of priority programs with the highest probability of success
Seek strategic partnerships to maximize value generation
Management
Precigen Leadership
Subsidiary Leadership
Precigen ActoBio
Precigen Exemplar